Все публикации

0:33:48

Primary biliary cholangitis: Appraising the changing therapeutic landscape

0:39:00

Treating moderate-to-severe atopic dermatitis in children and adolescents: Insights from the experts

0:40:30

Continuous glucose monitoring in type 2 diabetes: Overcoming barriers to optimize outcomes

0:37:54

Clinical decision making with immunotherapies in advanced or recurrent endometrial cancer

0:30:29

Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions

0:15:14

Current treatments and unmet needs in limited-stage small cell lung cancer

0:16:24

Expert insights in food allergy: Considerations for diagnosis & management in primary care & beyond

0:32:14

The rationale for protein degradation and immunomodulation in RRMM: Latest data and clinical trials

0:18:01

Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy

0:00:47

touchIME is proud of the way we're reshaping the continuing education landscape!

0:34:18

Guideline-based treatment of recurrent/metastatic cervical cancer

0:49:15

IgG4-related disease: How to identify, diagnose and treat

0:37:49

Paediatric atopic dermatitis: Evolving strategies for improved management

1:19:22

Clinical care pathway for Alzheimer’s disease: Driving improvements in diagnosis

0:16:58

Migraine prevention in the real world: Exploring the role of anti-CGRP antibodies

1:00:25

Expanding horizons in the treatment of endometrial cancer: ESGO 2023 guide clinical practice?

0:31:26

The mRNA vaccine platform: the rapid development of vaccines against respiratory viral infections

0:06:46

Prurigo nodularis: Improving awareness, diagnosis, management and quality of life

0:18:18

Migraine prevention in the real world: Exploring the role of anti-CGRP antibodies

0:12:01

The complement system in NMOSD and MG: A target for therapeutic benefit?

0:34:27

Fulfilling the potential of HER2-targeting in colorectal cancer: update on detection and management

0:18:22

MIGRAINE PREVENTION IN THE REAL WORLD: EXPLORING THE ROLE OF ANTI-CGRP ANTIBODIES

0:48:53

Latest developments in neuromyelitis optica spectrum disorder

0:33:29

Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management